Case Report: Treatment response of SQSTM1–ALK fusion lung adenocarcinoma to multiple ALK inhibitors

ObjectivesThe echinoderm microtubule-associated protein-like 4 (EML4) gene and anaplastic lymphoma kinase (ALK) gene fusion is the most common ALK rearrangement in non-small-cell lung cancer (NSCLC). SQSTM1 (exon 5)–ALK (exon 20) fusion in patients with NSCLC was first identified in 2015. However, t...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jincui Gu, Jing Zhang, Shaoli Li, Ziying Lin, Lixia Huang, Yanbin Zhou
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2025-09-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	lung adenocarcinoma SQSTM1–anaplastic lymphoma kinase fusion anaplastic lymphoma kinase inhibitors case report treatment
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1608080/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!